This CCJM review provides useful perspectives on the use of vancomycin and the newer antibiotics linezolid, quinupristin-dalfopristin, daptomycin and tygecycline. Note: since this paper’s publication daptomycin has been approved for S. aureus bacteremia including MRSA. Related post here.
Friday, November 24, 2006
Subscribe to:
Post Comments (Atom)
Posts
1 comments:
what about smz/tmp if c/s shows acceptable? it's super cheap and our state infx control has been pushing it
Post a Comment